Alyeska Investment Group
SILK

Alyeska Investment Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Alyeska Investment Group’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-166,168
Closed -$6.96M – 610
2020
Q2 		$6.96M Buy
166,168
+110,307
+197% +$4.23M 0.11% 232
2020
Q1 		$1.76M Sell
55,861
-257,786
-82% -$10.3M 0.04% 267
2019
Q4 		$12.7M Buy
313,647
+95,235
+44% +$3.33M 0.17% 156
2019
Q3 		$7.11M Buy
218,412
+53,323
+32% +$2.12M 0.1% 189
2019
Q2 		$8M Buy
+165,089
New +$7.02M 0.1% 188

Other funds holding SILK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alyeska Investment Group's SILK Position: Q3 2020 in Review

Alyeska Investment Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2020, closing a stake of 166,168 shares — an estimated $6.96M sold.

Alyeska Investment Group first reported a position in SILK in Q2 2019 and held it in 5 quarters. The position peaked at $12.7M in Q4 2019. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2020.

  • Alyeska Investment Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 166,168 Silk Road Medical, Inc. Common Stock shares in Q3 2020, an estimated $6.96M.
  • Alyeska Investment Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • Alyeska Investment Group's Silk Road Medical, Inc. Common Stock position peaked at $12.7M in Q4 2019.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2020.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.